COVID-19 Vaccine Study

You can earn up to $340 for your participation. This clinical trial studies an investigational COVID-19 vaccine to help protect against the JN.1 subvariant of COVID-19. The study is open to males and females ages 50–64, regardless of prior vaccination status.

Please complete the form below to be considered for the trial, or call us directly at 757-591-8100 for immediate assistance.

COVID-19 Vaccine Study

Phone

This field is for validation purposes and should be left unchanged.

Name(Required)

First Last

Email(Required)

Phone(Required)

Are you between 50 and 64 years old?(Required)

Yes

Do you have a smart phone in order to use an electronic diary?(Required)

Yes

How did you hear about this trial?

CAPTCHA

Take the First Step

Watch this quick video to learn how to join a clinical trial at HRHR, and what makes the experience simple and supportive.

Learn More About This COVID-19 Study

Post-marketing studies provide important information about how vaccines perform in the real world, especially for adults ages 50–64. By joining this COVID-19 post-marketing study, you’ll receive study-related medical care at no cost, compensation for your time, and the opportunity to directly support public health research.

read the article

Frequently Asked Questions

Learn more about participating in a clinical research trial.

Learn more

Meet our team

Our passion and profound knowledge of clinical research methodologies is what drives our commitment to elevating new possibilities for healthier lives.

meet our team